Search Results - "Mis, Ricard"

Effectiveness, pharmacokinetics, and safety of a new sustained-release leuprolide acetate 3.75-mg depot formulation for testosterone suppression in patients with prostate cancer: A phase III, open-label, international multicenter study by Marberger, Michael, MD, Kaisary, Amir V, MA, ChM, Shore, Neal D., MD, Karlin, Gary S., MD, Savulsky, Claudio, MD, Mis, Ricard, PhD, Leuratti, Chiara, PhD, Germa, Josep R., MD

“…Abstract Background: A microencapsulated, sustained-release formulation of leuprolide acetate 3.75 mg has been developed. Objective: This study investigated…”
Get full text

A phase I clinical and pharmacokinetic study (LIPOTEC - GP PHARM/DOXO 01) of a new liposomal doxorubicin given as 3-week schedule in patients with solid tumors by Majem, Margarita, Salazar, Ramon, Garcia, Margarita, Clopes, Ana, Muñoz, Carme, Pardo, Beatriz, Martinez, Marisa, Cuadra, Carmen, Montes, Ana, Mis, Ricard, Savulsky, Claudio, Ramon Germa-Lluch, Josep

“…As a dose-finding phase I study of a new liposomal formulation of doxorubicin (LipD), patients (n = 39; median age: 60 years; range, 41-75; median ECOG…”
Get full text

Pharmacokinetics of ketoprofen enantiomers in monkeys following single and multiple oral administration by Mauleon, D, Mis, R, Ginesta, J, Ortega, E, Vilageliu, J, Basi, N, Carganico, G

“…Pharmacokinetic studies are reported after single oral administration of 3 mg/kg of stereochemically pure (S)-ketoprofen [(S)-KP] and (R)-ketoprofen [(R)-KP]…”
Get more information

Stereoselective metabolic pathways of ketoprofen in the rat: Incorporation into triacylglycerols and enantiomeric inversion by Carabaza, Assumpta, Suesa, Nuria, Tost, Digna, Pascual, Jaume, Gomez, Manel, Gutierrez, Marta, Ortega, Elvira, Montserrat, Xavier, Garcia, Ana M., Mis, Ricard, Cabre, Francesc, Mauleon, David, Carganico, Germano

“…The enantiomeric bioinversion of ketoprofen (KP) enantiomers and their incorporation into triacylglycerols were investigated in the rat (1) in vitro, using…”
Get full text